Skip to main content

PAD 112 (Moexipril Hydrochloride 15 mg)

Pill with imprint PAD 112 is Beige, Round and has been identified as Moexipril Hydrochloride 15 mg. It is supplied by Paddock Laboratories, Inc.

Moexipril is used in the treatment of diabetic kidney disease; heart attack; heart failure; high blood pressure; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAD 112

Moexipril hydrochloride 15 mg PAD 112

Moexipril Hydrochloride

PAD 112
15 mg
8.00 mm
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Paddock Laboratories, Inc.
National Drug Code (NDC)
00574-0112 (Discontinued)
Inactive Ingredients
lactose monohydrate, crospovidone, magnesium oxide, povidone, silicon dioxide, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.